A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Trial details
- Registry ID
- NCT07541287
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of JADE101 in Participants With Immunoglobulin A NephropathyNCT07541287 | JBIO | Phase 2 | Recruiting | 2029-01Estimated |
| A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A NephropathyNCT07902817 | JBIO | Phase 3 | Recruiting | 2029-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |